Focal cerebral ischemia and hemostasis: A PAI-1 conundrum

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 7, 2005, Pages 1376-1378

  Del Zoppo, Gregory J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN INJURY; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; GENE OVEREXPRESSION; HEMOSTASIS; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE INJURY; NONHUMAN; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOSIS; ANIMAL; BRAIN; DISEASE MODEL; GENE DELETION; GENETICS; HUMAN; METABOLISM; MOUSE; MOUSE MUTANT; NERVE CELL; PATHOLOGY; PHOTOCHEMISTRY; PHYSIOLOGY; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM;

ANIMALS; BRAIN; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; GENE DELETION; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NEURONS; PHOTOCHEMISTRY; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 25144447421     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01465.x     Document Type: Note

References (27)

1. Tagaya M, Haring H-P, Stuiver I, Wagner S, Abumiya T, Lucero J, Lee P, Copeland BR, Seiffert D, del Zoppo GJ. Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury. J Cereb Blood Flow Metab 2001; 21: 835-46.
2. Chang DI, Hosomi N, Lucero J, Heo JH, Abumiya T, Mazar AP, del Zoppo GJ. Activation systems for matrix metalloproteinase-2 are upregulated immediately following experimental focal cerebral ischemic. J Cereb Blood Flow Metab 2003; 23: 1408-19.
3. Mabuchi T, Lucero J, Feng A, Koziol JA, del Zoppo GJ. Focal cerebral ischemia preferentially affects neurons distant from their neighboring microvessels. J Cereb Blood Flow Metab 2005; 25: 257-66.
4. del Zoppo GJ, Mabuchi T. Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab 2003; 23: 879-94.
5. Nagai N, Suzuki Y, Van Hoef B, Lijnen HR, Collen D. Effects of plasminogen activator inhibitor-1 on ischemic brain injury in permanent and thrombotic middle cerebral artery occlusion models in mice. J Thromb Haemost 2005; 3: 1379-84.
6. Rosenberg RD. Vascular-bed-specific hemostasis and hypercoagulable states. N Eng J Med 1999; 340: 1555-64.
7. 4 during focal cerebral ischemia/ reperfusion. Stroke 1997; 28: 858-65.
8. 3 during focal cerebral ischemia. J Cereb Blood Flow Metab 1999; 19: 1038-50.
9. Fukuda S, Fini CA, Mabuchi T, Koziol JA, Eggleston L, del Zoppo GJ. Focal cerebral ischemic active proteases that degrade neurovascular matrix. Stroke 2004; 35: 998-1004.
10. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord J, Collen D, Mulligan R. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994; 368: 419-24.
11. Carmeliet P, Kieckens L, Schoonjans L, Ream B, Van Nuffelen A, Prendergast G, Cole M, Bronson R, Collen D, Mulligan RC. Plasminogen activator inhibitor-1 gene-deficient mice, I: generation by homologous recombination and characterization. J Clin Invest 1993; 92: 2746-55.
12. Carmeliet P, Stassen JM, Schoonjans L, Ream B, van den Oord JJ, De Mol M, Malligan RC, Collen D. Plasminogen activator inhibitor-1 deficient mice, II: effects on hemostasis, thrombosis and thrombolysis. J Clin Invest 1993; 92: 2756-60.
13. Poplis VA, Carmeliet P, Vazirizadeh S, Van Vlaenderen I, Moons L, Plow EF, Collen D. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. J Clin Invest 1995; 92: 2585-93.
14. 2- Antiplasmin gene-deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding. Blood 1999; 93: 2274-81
15. Dewerchin M, Van Nuffelen A, Wallays G, Bouche A, Moons L, Carmeliet P, Malligan RC, Collen D. Generation and characterization of urokinase receptor-deficient mice. J Clin Invest 1996; 97: 870-8.
16. Tsirka SE, Rogove AD, Bugge TH, Degen JL, Strickland S. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 1997; 17: 543-52.
17. Chen ZL, Strickland S. Neuronal death in the hippocampus is promoted by plasmin catalyzed degradation of laminin. Cell 1997; 91: 917-25.
18. Nagai N, De Mol M, Lijnen HR, Carmeliet P, Collen D. Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice. Circulation 1999; 99: 2440-4.
19. Hosomi N, Lucero J, Heo JH, Koziol JA, Copeland BR, del Zoppo GJ. Rapid differential endogenous plasminogen activator expression after acute middle cerebral artery occlusion. Stroke 2001; 32: 1341-48.
20. Yi JS, Kim YH, Koh JY. Infarct reduction in rats following intraventricular administration of either tissue plasminogen activator (tPA) or its non-protease mutant S478A-tPA. Exp Neurol 2004; 189: 354-60.
21. Meng W, Wang X, Asahi M, Kano T, Asahi K, Ackerman RH, Lo EH. Effects of tissue type plasminogen activator in embolic versus mechanical models of focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1999; 19: 1316-21.
22. Kilic E, Kilic U, Bassetti C, Hermann DM. Intravenously administered recombinant tissue-plasminogen activator attenuates neuronal injury after mild focal cerebral ischemia in mice. Neuroreport 2004; 15: 687-9.
23. Okada Y, Copeland BK, Tung M-M, del Zoppo GJ. Fibrin forms in the perivascular tissue during focal cerebral ischemia and reperfusion. Stroke 1994; 25: 266.
24. Carmeliet P, Moons L, Lijnen R, Janssens S, Lupu F, Collen D, Gerard RD. Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation. Circulation 1997; 96: 3180-91.
25. Fox G, Gallacher D, Shevde S, Loftus J, Swayne G. Anatomic variation of the middle cerebral artery in the Sprague-Dawley rat. Stroke 1993; 24: 2087-92.
26. Maeda K, Hata R, Hossmann KA. Regional metabolic disturbances and cerebrovascular anatomy after permanent middle cerebral artery occlusion in C57black/6 and SV129 mice. Neurobiol Dis 1999; 6: 101-8.
27. Stutzmann JM, Mary V, Wahl F, Grosjean-Plot O, Uzan A, Pratt J. Neuroprotective profile of enoxaparin, a low molecular weight heparin, in in vivo models of cerebral ischemia or traumatic brain injury in rats: a review. CNS Drug Rev 2002; 8: 1-30.